ARCHIVES

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

This article is from The Cancer Letter archive.

Vol. 05 No. 24 | June 15, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

Pancreatic Cancer Pain Reduction Concept Approved

May 23, 1986

New Coalition To Lobby for Prevention

November 24, 1978

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004